Modelling the impact of a smallpox attack in India and influence of disease control measures.
infection control
public health
smallpox
vaccines
variola
virology
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
13 12 2020
13 12 2020
Historique:
entrez:
15
12
2020
pubmed:
16
12
2020
medline:
15
5
2021
Statut:
epublish
Résumé
To estimate the impact of a smallpox attack in Mumbai, India, examine the impact of case isolation and ring vaccination for epidemic containment and test the health system capacity under different scenarios with available interventions. The research is based on Mumbai, India population. We tested 50%, 70%, 90% of case isolation and contacts traced and vaccinated (ring vaccination) in the susceptible, exposed, infected, recovered model and varied the start of intervention between 20, 30 and 40 days after the initial attack. We estimated and incorporated in the model the effect of past vaccination protection, age-specific immunosuppression and contact rates and Mumbai population age structure in modelling disease morbidity and transmission. The estimated duration of an outbreak ranged from 127 days to 8 years under different scenarios, and the number of vaccine doses needed for ring vaccination ranged from 16 813 to 8 722 400 in the best-case and worst-case scenarios, respectively. In the worst-case scenario, the available hospital beds in Mumbai would be exceeded. The impact of a smallpox epidemic may be severe in Mumbai, especially compared with high-income settings, but can be reduced with early diagnosis and rapid response, high rates of case finding and isolation and ring vaccination. This study tells us that if smallpox re-emergence occurs, it may have significant health and economic impact, the extent of which will depend on the availability and delivery of interventions such as a vaccine or antiviral agent, and the capacity of case isolation and treatment. Further research on health systems requirements and capacity across the diverse states and territories of India could improve the preparedness and management strategies in the event of re-emergent smallpox or other serious emerging infections.
Identifiants
pubmed: 33318109
pii: bmjopen-2020-038480
doi: 10.1136/bmjopen-2020-038480
pmc: PMC7737064
doi:
Substances chimiques
Smallpox Vaccine
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e038480Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Emerg Infect Dis. 2018 Apr;24(4):646-653
pubmed: 29553311
J Educ Health Promot. 2018 Sep 14;7:117
pubmed: 30271802
N Engl J Med. 2002 Apr 25;346(17):1300-8
pubmed: 11923491
Rheumatology (Oxford). 2008 Jul;47(7):1088-92
pubmed: 18511475
Int J Tuberc Lung Dis. 2012 Sep;16(9):1270-7
pubmed: 22871327
Inflamm Intest Dis. 2017 Nov;2(2):102-115
pubmed: 30018961
Lancet Diabetes Endocrinol. 2014 Oct;2(10):778
pubmed: 25282085
J Autoimmun. 2009 Nov-Dec;33(3-4):197-207
pubmed: 19819109
PLoS One. 2017 Oct 26;12(10):e0185938
pubmed: 29073132
Natl Med J India. 2006 Jan-Feb;19(1):33-6
pubmed: 16570684
Expert Rev Vaccines. 2015 Jan;14(1):99-117
pubmed: 25373435
Am J Epidemiol. 2003 Jul 15;158(2):110-7
pubmed: 12851223
Epidemiol Infect. 2007 Oct;135(7):1145-50
pubmed: 17156499
Lupus. 1993 Apr;2(2):115-8
pubmed: 8330032
PLoS One. 2018 Feb 26;13(2):e0193320
pubmed: 29481563
Lancet Infect Dis. 2015 Mar;15(3):340-7
pubmed: 25661473
Mol Biol Evol. 2018 Nov 1;35(11):2607-2617
pubmed: 30099520
Am J Nurs. 1961 Dec;61:92-3
pubmed: 13872077
Biosecur Bioterror. 2014 May-Jun;12(3):117-21
pubmed: 24712454
Emerg Infect Dis. 2004 May;10(5):832-41
pubmed: 15200816
Viruses. 2019 Aug 27;11(9):
pubmed: 31462006
Epidemics. 2017 Jun;19:13-23
pubmed: 28038869
Indian J Med Paediatr Oncol. 2015 Apr-Jun;36(2):128-31
pubmed: 26157291
Am J Epidemiol. 2003 Oct 15;158(8):717-23
pubmed: 14561660
Indian J Med Res. 2014 Apr;139(4):491-511
pubmed: 24927336
Virology. 1995 Aug 1;211(1):350-5
pubmed: 7645234
Indian J Endocrinol Metab. 2012 Jul;16(4):569-74
pubmed: 22837918
J Cancer Res Ther. 2010 Jul-Sep;6(3):299-303
pubmed: 21119257
PLoS Comput Biol. 2017 Sep 12;13(9):e1005697
pubmed: 28898249
PLoS Curr. 2015 Feb 25;7:
pubmed: 25789200
Indian J Community Med. 2014 Jul;39(3):143-6
pubmed: 25136154
Interdiscip Perspect Infect Dis. 2009;2009:591935
pubmed: 19266090
Euro Surveill. 2016;21(5):6-11
pubmed: 26876980
Proc (Bayl Univ Med Cent). 2005 Jan;18(1):21-5
pubmed: 16200144
Virology. 1996 Jul 15;221(2):291-300
pubmed: 8661439
PLoS One. 2019 Jun 14;14(6):e0217704
pubmed: 31199825
Indian J Dermatol Venereol Leprol. 2010 Nov-Dec;76(6):595-601
pubmed: 21079301